Siemens
Siemens Healthineers Obtains CE Mark for COVID-19 Rapid Antigen Self-Test
The firm said that its rapid COVID-19 antigen self-test can be used unsupervised by people 12 and older, with or without symptoms, to detect the SARS-CoV-2 virus.
Siemens Healthineers Fiscal Q2 Dx Revenues Rise 23 Percent on COVID-19 Antigen Test Demand
The firm's Diagnostics segment booked total fiscal Q2 revenues of €190 million from rapid antigen tests for COVID-19 that were mainly distributed in Germany.
In Brief This Week: Exact Sciences, Siemens Healthineers, Seegene, Agilent Technologies, and More
News items for the in vitro diagnostics industry for the week of April 12, 2021.
Siemens Healthineers Gets CE Mark for Point-of-Care High-Sensitivity Cardiac Troponin I Test
The technology underlying the test was developed by Dutch firm Minicare, which was acquired by Siemens in 2019.
Siemens Healthineers Gets FDA Emergency Use Authorization for Coronavirus Antibody Test
The chemiluminescent immunoassay may be used by laboratories CLIA-certified to perform moderate- or high-complexity tests, the FDA said.